NCT01890447 - Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation | Biotech Hunter

Enrollment

676

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Pertussis

Interventions

OTHER

Web-based survey questionnaire

Data collection will be done via web-based questionnaires generated by Sawtooth Software. Subjects will be asked for their ideal alternative (acceptance to immunisation) by selecting the factors that suit them the most. The subjects are then presented several sets of alternatives built around their ideal choice.

Trial Locations (9)

12100

GSK Investigational Site, Cuneo

16043

GSK Investigational Site, Chiavari

28905

GSK Investigational Site, Getafe/Madrid

28982

GSK Investigational Site, Parla

31008

GSK Investigational Site, Pamplona

48940

GSK Investigational Site, Leioa( Vizcaya)

71016

GSK Investigational Site, San Severo (FG)

97100

GSK Investigational Site, Ragusa (RG)

08035

GSK Investigational Site, Barcelona